atorvastatin has been researched along with Acid Cholesteryl Ester Hydrolase Deficiency, Wolman Type in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertamino, M; Bertolini, S; Di Rocco, M; Madeo, A; Pisciotta, L | 1 |
1 other study(ies) available for atorvastatin and Acid Cholesteryl Ester Hydrolase Deficiency, Wolman Type
| Article | Year |
|---|---|
Long term substrate reduction therapy with ezetimibe alone or associated with statins in three adult patients with lysosomal acid lipase deficiency.
Topics: Adolescent; Alanine Transaminase; Atorvastatin; Child; Cholesterol; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Triglycerides; Wolman Disease | 2018 |